CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −4,332 | 2,888 | ||
| 2024-12-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −54,342 | 655,536 | ||
| 2024-12-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Class B Common Stock | +58,674 | 4,850,852 | ||
| 2024-12-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock | −36,163 | 4,814,689 | ||
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Option exercise | +26,511 | 203,999 | ||
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Sale | −14,853 | $22.61 | $336K | 189,146 |
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −1,981 | 1,321 | ||
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −5,096 | 13,589 | ||
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −8,879 | 76,958 | ||
| 2024-12-03 | Miller Steven Clive Chief Financial Officer | Option exercise · Restricted Stock Units | −10,555 | 133,689 | ||
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Conversion | +36,163 | 48,469 | ||
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Sale | −36,163 | $22.61 | $818K | 12,306 |
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −4,332 | 2,888 | ||
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −54,342 | 655,536 | ||
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Class B Common Stock | +58,674 | 6,520,584 | ||
| 2024-12-03 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock | −36,163 | 6,484,421 | ||
| 2024-10-18 | WILLIAMS RONALD A Director | Grant or award | +415 | 83,261 | ||
| 2024-09-13 | Gilboa David Abraham Co-Chief Executive Officer | Gift · Class B Common Stock | −400,000 | 1,656,770 | ||
| 2024-09-11 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −6,763 | $13.90 | $94K | 177,488 |
| 2024-09-10 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +49,034 | 61,340 |
Page 18 of 20 · 390 trades